Should a person with dementia who lacks decision‑making capacity and is refusing the influenza vaccine be administered the vaccine?

Should You Give the Flu Vaccine to Someone with Dementia Who Is Refusing and Unable to Make Their Own Medical Decisions?

Yes, you should administer the influenza vaccine to a person with dementia who lacks decision-making capacity and is refusing, because the substantial mortality and morbidity benefits of vaccination outweigh the person's objection when they cannot capably refuse, and public health considerations legitimately factor into best-interests determinations for vulnerable individuals.

The Clinical Imperative: Mortality and Morbidity Data

The evidence strongly supports vaccination in this population based on hard outcomes:

• Influenza vaccination reduces mortality by 9% and hospitalizations by 9-10% specifically in people with dementia 1. This 2025 Danish registry study of 134,002 people with dementia provides the most direct evidence for this exact population.

• Older adults (≥65 years) who receive influenza vaccination experience a 48% reduction in mortality risk and 27% reduction in hospitalization risk 2. Around 90% of flu-related deaths occur in older people 2.

• Beyond immediate flu complications, influenza vaccination is associated with 31% lower risk of incident dementia, 40% lower risk of Alzheimer's disease, and 58% lower risk of vascular dementia 3. This suggests vaccination provides neuroprotective benefits beyond infection prevention.

The Legal and Ethical Framework

When a person lacks decision-making capacity, the decision shifts to a legally authorized representative (LAR) using a best-interests standard 4. However, the best-interests analysis can and should incorporate public health considerations—not just the individual's past preferences 5.

Key principles:

• Persons with dementia should be presumed to have capacity unless established otherwise 4. However, once incapacity is confirmed, refusal may not represent a "capable" refusal 6.

• An "uninformed" objection from someone lacking capacity does not carry the same ethical weight as informed refusal 4. The 2018 Alzheimer's & Dementia guidelines note ongoing controversy about whether to respect uninformed objections, but emphasize that researchers and LARs should "take all reasonable efforts to support persons with dementia to make their own decisions" while recognizing that capacity-appropriate involvement may still result in proceeding with intervention 4.

• Public health considerations are ethically relevant: The 2022 analysis in Journal of Law and the Biosciences argues that "the interests of third parties become more salient" during public health emergencies, and "the public health impact of vaccination may in some instances be enough to outweigh preferences of the individual" 5.

Practical Algorithm for Decision-Making

Step 1: Assess Decision-Making Capacity

• Evaluate the person's ability to understand vaccination information, appreciate how it affects them, make a choice, and communicate it 6
• Having dementia does not automatically mean lack of capacity 6, 7
• Document the capacity assessment

Step 2: If Capacity Is Present

• Respect their informed refusal
• Provide education using simplified materials, visual aids, and familiar caregivers to support understanding 4

Step 3: If Capacity Is Absent

• Identify the LAR (guardian, healthcare proxy, or next of kin per local law)
• Conduct best-interests analysis that includes:
  • Medical benefits: 9% mortality reduction, 9-10% hospitalization reduction in dementia patients 1
  • Safety profile: Influenza vaccines are safe and well-tolerated with generally mild, transient adverse effects 2
  • Public health impact: Protection of other vulnerable individuals in congregate settings
  • Past preferences (if known through advance directives)
  • Current behavioral responses (assent/dissent)

Step 4: Address the Refusal Behavior

• Distinguish between incapable resistance and capable refusal 4, 6
• Use supportive approaches: familiar caregivers present, calm environment, process consent approach 4
• Consider timing (when patient is calmer, less agitated)
• Proceed with vaccination if best-interests analysis favors it, even in the presence of behavioral resistance 5, 6

Critical Caveats

Dementia is paradoxically associated with lower vaccination rates (OR: 0.78) 8, suggesting systemic barriers to vaccinating this vulnerable population. This makes proactive decision-making even more important.

Contraindications still apply: Do not vaccinate if there is history of severe allergic reaction to vaccine components or previous influenza vaccine 9. Egg allergy requires supervised administration 2.

The refusal may reflect delirium, not baseline dementia: If acute change in mental status, address underlying causes first 6.

Why This Approach Is Justified

The evidence hierarchy strongly supports vaccination:

1. Guideline consensus: Multiple international societies recommend influenza vaccination for older adults and those with chronic conditions, with 75% coverage targets 2

2. FDA labeling: Fluzone is approved for persons 6 months and older without specific exclusions for dementia or behavioral resistance 9

3. Dementia-specific outcomes: The 2025 study provides direct evidence of benefit in this exact population 1

4. Ethical framework: The 2022 bioethics analysis explicitly supports weighing public health considerations when individuals lack capacity to refuse 5

The key insight: When someone cannot capably refuse (lacks decision-making capacity), their behavioral resistance does not constitute informed refusal. The LAR's best-interests determination—incorporating substantial mortality/morbidity benefits and public health considerations—takes precedence over uninformed objection 5, 6.